Loading...
Loading...
By MBN Staff - Wed, 03/27/2024 - 16:00
Merck's Winrevair targets PAH's root cause, offering hope beyond symptom management. FDA approval marks a milestone in cardiovascular care.
https://mexicobusiness.news/tag/merck
More Health
By Miriam Bello - Tue, 01/04/2022 - 13:14
Vertical supply chain integration enables Indian pharmaceutical company Dr. Reddy to offer the treatment at a smaller cost.
By Antonio Gozain - Fri, 12/24/2021 - 12:48
Molnupiravir, which halves the chances of dying or being hospitalized for severe COVID-19 illness, could become available in Mexico by 2022.
By Miriam Bello - Mon, 12/06/2021 - 10:18
Patient-accessible medical devices can influence health outcomes.
By Miriam Bello - Tue, 11/30/2021 - 10:45
Merck’s new fertility treatment device improves comfort and is easier to use than conventional methods, which should improve patient adherence.
By Miriam Bello - Wed, 11/24/2021 - 15:08
Pharmaceutical companies are developing oral treatments and vaccines to fight the COVID-19 pandemic.
By Antonio Gozain - Mon, 11/08/2021 - 13:38
Pfizer continues moving forward with its COVID-19 treatment, following the UK’s MHRA emergency use authorization of Merck’s molnupiravir.
By Antonio Gozain - Fri, 11/05/2021 - 13:16
The UK’s MHRA approved molnupiravir, the first COVID-19 oral treatment, for its emergency use.
By Antonio Gozain - Thu, 10/28/2021 - 11:21
Generic drugmakers are expected to market molnupiravir for US$20 per treatment, compared to the US$712 that the US government agreed to pay Merck.
By Miriam Bello - Thu, 10/07/2021 - 14:38
Health budgets, medicine distribution and market changes are discussed in this week’s roundup.
